በTexas ለሜዱሎብላስቶማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሜዱሎብላስቶማ የሚደረጉ 8 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በTexas ውስጥ ያሉ ከተሞች
Official study text (English)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
59 Months · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 19 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 1
36 Months – 22 Years · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ3 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ4 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
ተሳታዮችን በመፈለግ ላይደረጃ 2
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT04696029ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።